How season and serotype determine dengue transmissibility

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 26, 2014, Pages 9370-9371

  Ferguson, Neil M ^a   Cummings, Derek A T ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; EPIDEMIOLOGICAL DATA; HUMAN; INFECTION CONTROL; NONHUMAN; NOTE; PRIORITY JOURNAL; SEASONAL VARIATION; SEROTYPE; SPECIES DIVERSITY; STRAIN DIFFERENCE; VIRUS STRAIN; VIRUS TRANSMISSION;

DENGUE; DENGUE VIRUS; HUMANS; MODELS, BIOLOGICAL; PUBLIC HEALTH SURVEILLANCE;

EID: 84903740093     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1407648111     Document Type: Note

References (30)

1. Bhatt S, et al. (2013) The global distribution and burden of dengue. Nature 496(7446):504-507.
2. Nguyet MN, et al. (2013) Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes. Proc Natl Acad Sci USA 110(22):9072-9077.
3. Mammen MP, et al. (2008) Spatial and temporal clustering of dengue virus transmission in Thai villages. PLoS Med 5(11):e205.
4. Weaver SC, Vasilakis N (2009) Molecular evolution of dengue viruses: Contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol 9(4):523-540.
5. Anderson KB, et al. (2007) Burden of symptomatic dengue infection in children at primary school in Thailand: A prospective study. Lancet 369(9571):1452-1459.
6. Johansson MA, Hombach J, Cummings DA (2011) Models of the impact of dengue vaccines: A review of current research and potential approaches. Vaccine 29(35):5860-5868.
7. Sabchareon A, et al. (2012) Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial. Lancet 380(9853):1559-1567.
8. McMeniman CJ, et al. (2009) Stable introduction of a lifeshortening Wolbachia infection into the mosquito Aedes aegypti. Science 323(5910):141-144.
9. Walker T, et al. (2011) The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature 476(7361): 450-453.
10. Reiner RC, Jr, et al. (2014) Time-varying, serotype-specific force of infection of dengue virus. Proc Natl Acad Sci USA 111:E2694-E2702.
11. Rodríguez-Barraquer I, et al. (2014) Revisiting Rayong: Shifting seroprofiles of dengue in Thailand and their implications for transmission and control. Am J Epidemiol 179(3):353-360.
12. Ferguson NM, Donnelly CA, Anderson RM (1999) Transmission dynamics and epidemiology of dengue: Insights from age-stratified sero-prevalence surveys. Philos Trans R Soc Lond B Biol Sci 354(1384): 757-768.
13. Althouse BM, et al. (2014) Viral kinetics of primary dengue virus infection in non-human primates: A systematic review and individual pooled analysis. Virology 452-453:237-246.
14. Tricou V, Minh NN, Farrar J, Tran HT, Simmons CP (2011) Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl Trop Dis 5(9):e1309.
15. Nishiura H, Halstead SB (2007) Natural history of dengue virus (DENV)-1 and DENV-4 infections: Reanalysis of classic studies. J Infect Dis 195(7):1007-1013.
16. Fried JR, et al. (2010) Serotype-specific differences in the risk of dengue hemorrhagic fever: An analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4(3):e617.
17. Balmaseda A, et al. (2006) Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 74(3):449-456.
18. Vaughn DW, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181(1):2-9.
19. Cummings DA, et al. (2009) The impact of the demographic transition on dengue in Thailand: Insights from a statistical analysis and mathematical modeling. PLoS Med 6(9):e1000139.
20. Egger JR, et al. (2008) Reconstructing historical changes in the force of infection of dengue fever in Singapore: Implications for surveillance and control. Bull World Health Organ 86(3):187-196.
21. Reich NG, et al. (2013) Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. J R Soc Interface 610(86):20130414.
22. Luz PM, Mendes BV, Codeço CT, Struchiner CJ, Galvani AP (2008) Time series analysis of dengue incidence in Rio de Janeiro, Brazil. Am J Trop Med Hyg 79(6):933-939.
23. Adams B, et al. (2006) Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci USA 103(38): 14234-14239.
24. Montoya M, et al. (2013) Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis 7(8):e2357.
25. van Panhuis WG, et al. (2010) Inferring the serotype associated with dengue virus infections on the basis of pre-and postinfection neutralizing antibody titers. J Infect Dis 202(7):1002-1010.
26. Gluskin RT, Johansson MA, Santillana M, Brownstein JS (2014) Evaluation of Internet-based dengue query data: Google Dengue Trends. PLoS Negl Trop Dis 8(2):e2713.
27. Paolotti D, et al. (2014) Web-based participatory surveillance of infectious diseases: The Influenzanet participatory surveillance experience. Clin Microbiol Infect 20(1):17-21.
28. Chan EH, Sahai V, Conrad C, Brownstein JS (2011) Using web search query data to monitor dengue epidemics: A new model for neglected tropical disease surveillance. PLoS Negl Trop Dis 5(5):e1206.
29. Ginsberg J, et al. (2009) Detecting influenza epidemics using search engine query data. Nature 457(7232):1012-1014.
30. Hayward AC, et al. (2014) Comparative community burden and severity of seasonal and pandemic influenza: Results of the Flu Watch cohort study. Lancet Respir Med, 10.1016/S2213-2600(14) 70034-7.